OV21/PETROC: A randomized gynecologic cancer intergroup phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer

D. M. Provencher, C. J. Gallagher, W. R. Parulekar, J. A. Ledermann, D. K. Armstrong, M. Brundage, C. Gourley, I. Romero, A. Gonzalez-Martin, M. Feeney, P. Bessette, M. Hall, J. I. Weberpals, G. Hall, S. K. Lau, P. Gauthier, M. Fung-Kee-Fung, E. A. Eisenhauer, C. Winch, D. TuH. J. Mackay

Research output: Contribution to journalComment/debate

Fingerprint Dive into the research topics of 'OV21/PETROC: A randomized gynecologic cancer intergroup phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer'. Together they form a unique fingerprint.